Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment.
Oncotarget
; 9(72): 33719-33733, 2018 Sep 14.
Article
in En
| MEDLINE
| ID: mdl-30263098
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncotarget
Year:
2018
Document type:
Article